U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07374731) titled 'Identification of Biomarkers of Risk for Pre-neoplastic and Neoplastic Lesions for the Development of Gastric Cancer.' on Jan. 21.
Brief Summary: We propose the implementation of circulating biomarker monitoring, focusing on molecules related to the progression of gastric atrophy and/or associated with gastric cancer.
Monitoring these biomarkers will provide gastroenterologists with timely information on individuals at risk and, if values worsen during follow-up, will alert physicians observing these patients to evaluate them.
This monitoring will be offered to individuals who contact the IBO unit at the CRO in Aviano requesting a...